Long-Term Outcomes of Coronary Artery Bypass Grafting in Veterans with Ischemic Cardiomyopathy
Keywords:ischemic cardiomyopathy, veterans, CABG, Off-pump CABG
Background: The Surgical Treatment for Ischemic Heart Failure (STICH) trial showed that surgical revascularization in ischemic cardiomyopathy (ICM) patients improves long-term mortality compared with medical treatment alone. This study examines how veterans with ICM undergoing revascularization fare against patients without ICM; it also examines the outcomes in the veteran population.
Methods: This is a retrospective review of a single-center database. From 2000 to 2018, 1,461 patients underwent isolated coronary artery bypass grafting (CABG). Two-hundred-one patients with an ejection fraction less than 35% were classified as the ICM cohort. The primary outcome was mortality. Secondary outcomes included postoperative complications. Subgroup analysis was performed within the ICM cohort comparing off-pump CABG (OPCAB) versus on-pump
Results: ICM patients had a higher incidence of myocardial infarction (MI), diabetes, chronic kidney disease (CKD), and preoperative intra-aortic balloon pump (IABP) use. The non-ICM cohort was more functionally independent. OPCAB was performed in 80.1% of ICM and 66.3% of non-ICM cohorts. There was no statistical difference between ICM and non-ICM cohorts in 30-day mortality (OR 1.94[0.79 – 4.75], P = .15). The ICM cohort had an increased 5-year mortality (OR 1.75[1.14 – 2.69], P = .01) and 10-year mortality (OR 1.71[1.09 - 2.67], P = .02). The ICM cohort showed improved, although not statistically significant, short-term mortality with OPCAB compared with ONCAB (3.1% versus 12.5%, OR 0.31[0.05 – 1.82], P = .20).
Conclusion: Veterans with ICM undergoing CABG demonstrated similar short-term survival compared with non-ICM veterans. The long-term survival in the ICM cohort still is inferior to patients without ICM. There is a trend toward improved short-term survival in patients with ICM undergoing OPCAB.
Assari S. 2014. Veterans and risk of heart disease in the United States: A cohort with 20 years of follow up. Int J Prev Med 5(6):703-709.
Benjamin EJ, Virani SS, Callaway CW, et al. 2018. Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association. Circulation 137(12):e67-e492.
Dewey TM, Herbert MA, Prince SL, et al. 2004. Avoidance of Cardiopulmonary Bypass Improves Early Survival in Multivessel Coronary Artery Bypass Patients with Poor Ventricular Function. Heart Surg Forum 7(1):45-50.
Diegeler A, Börgermann J, Kappert U, et al. 2019. Five-Year Outcome after Off-Pump or On-Pump Coronary Artery Bypass Grafting in Elderly Patients. Circulation 139(16):1865-1871.
Groeneveld PW, Medvedeva EL, Walker L, Segal AG, Richardson DM, Epstein AJ. 2018. Outcomes of Care for Ischemic Heart Disease and Chronic Heart Failure in the Veterans Health Administration. JAMA Cardiology 3(7):563.
Lamy A, Devereaux PJ, Prabhakaran D, et al. 2016 Five-Year Outcomes after Off-Pump or On-Pump Coronary-Artery Bypass Grafting. New England Journal of Medicine 375(24):2359-2368.
Lee DH, Buth KJ, Martin B, Yip AM, Hirsch GM. 2010. Frail patients are at increased risk for mortality and prolonged institutional care after cardiac surgery. Circulation 121(8):973-978.
Matula SR, Trivedi AN, Miake-Lye I, Glassman PA, Shekelle P, Asch S. 2010. Comparisons of quality of surgical care between the US department of veterans affairs and the private sector. J Am Coll Surg 211(6):823-832.
Puskas JD, Thourani VH, Kilgo P, et al. 2009. Off-pump coronary artery bypass disproportionately benefits high-risk patients. Ann Thorac Surg 88(4):1142-1147.
Rezapour A, Bagheri Faradonbeh S, Alipour V, Yusefvand M. 2018. Effectiveness of revascularization interventions compared with medical therapy in patients with ischemic cardiomyopathy: A systematic review protocol. Medicine (Baltimore) 97(10):e9958.
Rosenthal GE, Vaughan Sarrazin M, Hannan EL. 2003. In-hospital mortality following coronary artery bypass graft surgery in veterans health administration and private sector hospitals. Med Care 41(4):522-535.
Saxena A, Dinh D, Smith JA, Shardey G, Reid CM, Newcomb AE. 2012. Sex differences in outcomes following isolated coronary artery bypass graft surgery in Australian patients: Analysis of the Australasian society of cardiac and thoracic surgeons cardiac surgery database. Eur J Cardiothorac Surg 41(4):755-762.
Saxena A, Shan L, Reid C, et al. 2013. Impact of smoking status on early and late outcomes after isolated coronary artery bypass graft surgery. J Cardiol 61(5):336-341.
Sellke FW, DiMaio JM, Caplan LR, et al. 2005. Comparing on-pump and off-pump coronary artery bypass grafting: Numerous studies but few conclusions: A scientific statement from the American heart association council on cardiovascular surgery and anesthesia in collaboration with the interdisciplinary working group on quality of care and outcomes research. Circulation 111(21):2858-2864.
Sepehripour AH, Harling L, Ashrafian H, Casula R, Athanasiou T. 2014. Does off-pump coronary revascularization confer superior organ protection in re-operative coronary artery surgery? A meta-analysis of observational studies. J Cardiothrac Surg 9:115.
Sepehripour AH, Saso S, Harling L, Punjabi P, Ashrafian H, Athanasiou T. 2013. Does off-pump coronary revascularization reduce mortality in re-operative coronary artery surgery? A meta-analysis of observational studies. Perfusion 28(4):340-349.
Shroyer AL, Hattler B, Wagner TH, et al. 2017. Five-Year Outcomes after On-Pump and Off-Pump Coronary-Artery Bypass. New England Journal of Medicine 377(7):623-632.
Sørensen LT. 2012. Wound healing and infection in surgery: The pathophysiological impact of smoking, smoking cessation, and nicotine replacement therapy: A systematic review. Ann Surg 255(6):1069-1079.
Trachiotis GD, Weintraub WS, Johnston TS, Jones EL, Guyton RA, Craver JM. 1998. Coronary Artery Bypass Grafting in Patients with Advanced Left Ventricular Dysfunction. Ann Thorac Surg 66:1632-9.
Velazquez EJ, Lee KL, Jones RH, et al. 2016. Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy. New England Journal of Medicine 374(16):1511-1520.